Experimental Ebola antibody protects monkeys

Scientists have discovered that a single monoclonal antibody isolated from a human Ebola virus disease survivor protected non-human primates when given as late as five days after lethal Ebola infection. The antibody can now advance to testing in humans as a potential treatment for Ebola virus disease. There are currently no licensed treatments for Ebola infection, which caused more than 11,000 deaths in the 2014-2015 outbreak in West Africa. —> Read More

facebooktwittergoogle_plusredditpinterestlinkedinmail